Palo Alto, United States
Inceptive, founded in 2021 and headquartered in the United States, is pioneering in the realm of biotechnology and artificial intelligence. Its slogan, "Foundation models of life, for life," encapsulates their mission to innovate in drug discovery.
The company specializes in creating end-to-end foundation models that design molecules from life's diverse observations. Their expertise lies in sequence-based medicines such as mRNA, siRNA, ASOs, and peptides, where sequencing is vital for functional success. By partnering with leading drug manufacturers, Inceptive tailors foundation models to bolster drug discovery programs, collaboratively designing transformative medicines.
Their multi-disciplinary team of scientists, AI researchers, and engineers engages in antedisciplinary efforts, integrating diverse fields to foster innovation. Although Inceptive is currently seeking investments, past investment details are unavailable. The company is actively hiring professionals in AI and bio, emphasizing a culture of constant questioning and data-driven development to push the boundaries of medicine.
